Analysed ARTELO BIOSCIENCES INC (ARTL:NASDAQ) News Sources
Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury
01-07-2026
yahoo.com
Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy
13-07-2026
yahoo.com
Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026
14-07-2026
yahoo.com
Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions
16-07-2026
yahoo.com
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition
22-07-2026
yahoo.com
Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
13-08-2026
yahoo.com
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
17-08-2026
yahoo.com
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
23-09-2026
yahoo.com
What is the current price of ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?
The current price of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is $3.26.
ARTELO BIOSCIENCES INC (ARTL:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) since the previous trading day is $-0.11.
ARTELO BIOSCIENCES INC (ARTL:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) since the previous trading day is -3.2641%.
What is the most recent average sentiment score for ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?
The most recent average sentiment score for ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?
The most recent sentiment for ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is .
SEC-8K** Filing Available For ARTELO BIOSCIENCES INC (ARTL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.